Linked Life Data

12574392

Source:http://linkedlifedata.com/resource/pubmed/id/12574392

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12574392rdf:typepubmed:Citationlld:pubmed
pubmed-article:12574392lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:12574392lifeskim:mentionsumls-concept:C0033085lld:lifeskim
pubmed-article:12574392lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:12574392lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:12574392lifeskim:mentionsumls-concept:C0085247lld:lifeskim
pubmed-article:12574392lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:12574392lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:12574392lifeskim:mentionsumls-concept:C1705822lld:lifeskim
pubmed-article:12574392lifeskim:mentionsumls-concept:C0348011lld:lifeskim
pubmed-article:12574392lifeskim:mentionsumls-concept:C0037791lld:lifeskim
pubmed-article:12574392lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:12574392lifeskim:mentionsumls-concept:C0205232lld:lifeskim
pubmed-article:12574392pubmed:issue4lld:pubmed
pubmed-article:12574392pubmed:dateCreated2003-2-7lld:pubmed
pubmed-article:12574392pubmed:abstractTextTCR with known antitumor reactivity can be genetically introduced into primary human T lymphocytes and provide promising tools for immunogene therapy of tumors. We molecularly characterized two distinct TCRs specific for the same HLA-A2-restricted peptide derived from the melanocyte differentiation Ag gp100, yet exhibiting different stringencies in peptide requirements. The existence of these two distinct gp100-specific TCRs allowed us to study the preservation of peptide fine specificity of native TCRalphabeta when engineered for TCR gene transfer into human T lymphocytes. Retroviral transduction of primary human T lymphocytes with either one of the two sets of TCRalphabeta constructs enabled T lymphocytes to specifically kill and produce TNF-alpha when triggered by native gp100(pos)/HLA-A2(pos) tumor target cells as well as gp100 peptide-loaded HLA-A2(pos) tumor cells. Peptide titration studies revealed that the cytolytic efficiencies of the T lymphocyte transductants were in the same range as those of the parental CTL clones. Moreover, primary human T lymphocytes expressing either one of the two engineered gp100-specific TCRs show cytolytic activities in response to a large panel of peptide mutants that are identical with those of the parental CTL. The finding that two gp100-specific TCR, derived from two different CTL, can be functionally introduced into primary human T lymphocytes without loss of the Ag reactivity and peptide fine specificity, holds great promise for the application of TCR gene transfer in cancer immunotherapy.lld:pubmed
pubmed-article:12574392pubmed:languageenglld:pubmed
pubmed-article:12574392pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12574392pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12574392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12574392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12574392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12574392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12574392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12574392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12574392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12574392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12574392pubmed:statusMEDLINElld:pubmed
pubmed-article:12574392pubmed:monthFeblld:pubmed
pubmed-article:12574392pubmed:issn0022-1767lld:pubmed
pubmed-article:12574392pubmed:authorpubmed-author:AdemaGosse...lld:pubmed
pubmed-article:12574392pubmed:authorpubmed-author:FigdorCarl...lld:pubmed
pubmed-article:12574392pubmed:authorpubmed-author:WillemsenRalp...lld:pubmed
pubmed-article:12574392pubmed:authorpubmed-author:DebetsRenoRlld:pubmed
pubmed-article:12574392pubmed:authorpubmed-author:GratamaJan-Wi...lld:pubmed
pubmed-article:12574392pubmed:authorpubmed-author:SchaftNielsNlld:pubmed
pubmed-article:12574392pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:12574392pubmed:authorpubmed-author:LankiewiczBir...lld:pubmed
pubmed-article:12574392pubmed:authorpubmed-author:EssersBram...lld:pubmed
pubmed-article:12574392pubmed:authorpubmed-author:BolhuisReinie...lld:pubmed
pubmed-article:12574392pubmed:issnTypePrintlld:pubmed
pubmed-article:12574392pubmed:day15lld:pubmed
pubmed-article:12574392pubmed:volume170lld:pubmed
pubmed-article:12574392pubmed:ownerNLMlld:pubmed
pubmed-article:12574392pubmed:authorsCompleteYlld:pubmed
pubmed-article:12574392pubmed:pagination2186-94lld:pubmed
pubmed-article:12574392pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:meshHeadingpubmed-meshheading:12574392...lld:pubmed
pubmed-article:12574392pubmed:year2003lld:pubmed
pubmed-article:12574392pubmed:articleTitlePeptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes.lld:pubmed
pubmed-article:12574392pubmed:affiliationClinical and Tumor Immunology, Department of Medical Oncology, Erasmus Medical Center-Daniel den Hoed, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands.lld:pubmed
pubmed-article:12574392pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12574392pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12574392lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12574392lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12574392lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12574392lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12574392lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12574392lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12574392lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12574392lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12574392lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12574392lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12574392lld:pubmed